Chemotherapy Research Today is a free monthly online journal that collates and summarizes the latest research about Chemotherapy, including details on cancer treatment, side effects, drugs.

Immunologic and clinical responses to highly active antiretroviral therapy in patients with HIV infection aged >50 years.

Cuzin L, Delpierre C, Gerard S, Massip P, Marchou B

Department of Infectious and Tropical Diseases, Hopital Purpan, Toulouse, France. cuzin.l@chu-toulouse.fr

We analyzed the effect of age on highly active antiretroviral therapy efficacy and tolerance in 639 patients with human immunodeficiency virus (HIV) infection (99 of whom were aged >50 years, and 540 of whom were aged <50 years). Late testing, which was more frequent in the older age group, was the only independent factor associated with immunologic and clinical evolution of infection. Age >50 years was associated with earlier treatment discontinuation.

Published 8 August 2007 in Clin Infect Dis, 45(5): 654-7.
Full-text of this article is available online (may require subscription).

© 2004-2008 Chemotherapy Research Today. All Rights Reserved.